BDKRB2 Antikörper (AA 357-391)
Kurzübersicht für BDKRB2 Antikörper (AA 357-391) (ABIN5647061)
Target
Alle BDKRB2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 357-391
-
Verwendungszweck
- BDKRB2 Antibody / B2 bradykinin receptor
-
Sequenz
- RSEPIQMENS MGTLRTSISV ERQIHKLQDW AGSRQ
-
Aufreinigung
- Antigen affinity
-
Immunogen
- Amino acids 357-391 (RSEPIQMENSMGTLRTSISVERQIHKLQDWAGSRQ) from the human protein were used as the immunogen for the BDKRB2 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Differences in protocols and secondary/substrate sensitivity may require the BDKRB2 antibody to be titrated for optimal performance.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the BDKRB2 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- BDKRB2 (Bradykinin Receptor B2 (BDKRB2))
-
Andere Bezeichnung
- BDKRB2
-
Hintergrund
- Bradykinin receptor B2 is a G-protein coupled receptor forbradykinin, encoded by the BDKRB2 gene in humans. This gene encodes a receptor for bradykinin. The 9 aa bradykinin peptide elicits many responses including vasodilation, edema, smooth muscle spasm and pain fiber stimulation. This receptor associates with G proteins that stimulate a phosphatidylinositol-calcium second messenger system. Alternate start codons result in two isoforms of the protein.
-
UniProt
- P30411
-
Pathways
- ACE Inhibitor Pathway, Negative Regulation of intrinsic apoptotic Signaling
Target
-